DK113146B - Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.

Info

Publication number
DK113146B
DK113146B DK524265AA DK524265A DK113146B DK 113146 B DK113146 B DK 113146B DK 524265A A DK524265A A DK 524265AA DK 524265 A DK524265 A DK 524265A DK 113146 B DK113146 B DK 113146B
Authority
DK
Denmark
Prior art keywords
pregnadien
diones
delta
methylene
esters
Prior art date
Application number
DK524265AA
Other languages
English (en)
Inventor
Ag Schering
Original Assignee
Ag Schering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ag Schering filed Critical Ag Schering
Publication of DK113146B publication Critical patent/DK113146B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK524265AA 1964-10-13 1965-10-13 Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere. DK113146B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC035945 1964-10-13

Publications (1)

Publication Number Publication Date
DK113146B true DK113146B (da) 1969-02-24

Family

ID=7433676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524265AA DK113146B (da) 1964-10-13 1965-10-13 Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&Delta<4,6>-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.

Country Status (12)

Country Link
US (1) US3439093A (da)
BE (1) BE670874A (da)
BR (1) BR6573967D0 (da)
CH (1) CH472397A (da)
DK (1) DK113146B (da)
FI (1) FI42718B (da)
FR (1) FR6839M (da)
GB (1) GB1050218A (da)
IL (1) IL24357A (da)
NL (1) NL148615B (da)
NO (1) NO126737B (da)
SE (1) SE324362B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496273A (en) * 1967-03-23 1970-02-17 Schering Ag 1,2,alpha-methylenesteroids
DE1643027B2 (de) * 1967-06-09 1977-12-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern

Also Published As

Publication number Publication date
US3439093A (en) 1969-04-15
CH472397A (de) 1969-05-15
GB1050218A (da)
DE1493156A1 (de) 1969-08-07
NL148615B (nl) 1976-02-16
IL24357A (en) 1969-05-28
BE670874A (da) 1966-04-13
FR6839M (da) 1969-04-08
BR6573967D0 (pt) 1973-08-02
NO126737B (da) 1973-03-19
FI42718B (da) 1970-06-30
SE324362B (da) 1970-06-01
NL6512923A (da) 1966-04-14

Similar Documents

Publication Publication Date Title
DK116128B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK112949B (da) Fremgangsmåde til fremstilling af O-mycaminosyl-tylonolid eller dihydro-O-mycaminosyl-tylonolid.
DK117631B (da) Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner.
DK105157C (da) Fremgangsmåde til fremstilling af Δ&lt;1,4&gt;-16-α-metylsteroider.
DK123170B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-oxo-7α-methyl-Δ&lt;4,9,11&gt;-estratriener.
DK117894B (da) Analogifremgangsmåde til fremstilling af 17aα-metyl-17aβ-hydroksy-D-homo-Δ&lt;4,6&gt;-androstadien-3,17-dioner eller deres estere.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK126111B (da) Fremgangsmåde til fremstilling af Δ&lt;5,10&gt;-steroider med cyclopentanoperhydrophenanthrenstruktur.
DK120701B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 17β-tetrahydropyranylethere af Δ&lt;1,3,5(10)&gt;-østratrien-3-ol-eller 3-ethere eller 3-estere deraf.
DK118557B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-11β-hydroxy-Δ&lt;4&gt;-pregnen-3,20-dioner.
DK114060B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK113146B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&amp;Delta&lt;4,6&gt;-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.
DK114267B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17β-trialkylsiloxy-Δ&lt;4&gt;-androstener eller - estrener.
DK104346C (da) Fremgangsmåde til fremstilling af 6-metylen-3-oxo-Δ&lt;4&gt;-steroider.
DK103396C (da) Fremgangsmåde til fremstilling af estere af 17α-ethynyl-5(10)-estren-3β,17β-diol.
DK111141B (da) Fremgangsmåde til fremstilling af 2&#39;-acetamido-2&#39;-desoxyglucosider eller -galactosider af 17α,21-dihydroxy-11-oxygenerede -3,20-diketo-steroider af pregnanrækken.
DK122452B (da) Analogifremgangsmåde til fremstilling af 21-estere af 6α-halogen-16α-methyl-Δ&lt;1,4&gt;-pregnadien-11β,21-diol-3,20-dioner.
DK120746B (da) Analogifremgangsmåde til fremstilling af 4-klor-1,2α-metylen-Δ&lt;4,6&gt;-pregnadien-17α-ol-3,20-dion eller 17-estere deraf.
DK99358C (da) Fremgangsmåde til fremstilling af 1,17α-dialkyl-Δ&lt;1&gt;-androsten-17β-ol-3-oner eller deres 17-estere.
DK99568C (da) Fremgangsmåde til fremstilling af 1-alkyl-Δ&lt;1&gt;-androsten-17β-ol-3-oner eller deres 17-estere.
DK104786C (da) Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ&lt;4,6&gt;-steroider.
DK103939C (da) Fremgangsmåde til fremstilling af 17-estere 18-homo-19-nortestosteron eller 3-enolacylater deraf.
DK116869B (da) Fremgangsmåde til fremstilling af 6-methyl-16-fluormethylen-4-pregnen-3,20-dionderivater.
DK118556B (da) Analogifremgangsmåde til fremstilling af 16α-methyl-9α-chlor-Δ&lt;1,4&gt;-pregnadien-11β,21-diol-3,20-dioner eller 21-estere deraf.
DK128606B (da) Fremgangsmåde til fremstilling af 16β-metylprednison eller 21-acetatet deraf.